瑛泰医疗续签2025-2027年销售框架协议

地产k线09-23

瑛泰医疗（股票代码：01501）近日发布了补充公告，详细阐述了与康德莱的持续关联交易情况。公告指出，针对2025年至2027年的销售框架协议，双方将遵循公开招标程序来确定介入医疗器械的采购价格。定价机制将综合考虑地方政府的竞标规范、物流市场费用，以及瑛泰医疗自身的生产成本与市场合理利润率。此番设定的年度交易上限，是基于过往瑛泰医疗与康德莱的交易记录，并预见到中国医疗器械带量采购政策下市场需求增长的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2469744131?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-23 10:17","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2469744131","market":"hk","top_or_hot":-1,"title":"瑛泰医疗续签2025-2027年销售框架协议","media":"地产k线","content":"<div>\n<p>瑛泰医疗（股票代码：01501）近日发布了补充公告，详细阐述了与康德莱的持续关联交易情况。公告指出，针对2025年至2027年的销售框架协议，双方将遵循公开招标程序来确定介入医疗器械的采购价格。定价机制将综合考虑地方政府的竞标规范、物流市场费用，以及瑛泰医疗自身的生产成本与市场合理利润率。此番设定的年度交易上限，是基于过往瑛泰医疗与康德莱的交易记录，并预见到中国医疗器械带量采购政策下市场需求增长的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092310253495765695&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑛泰医疗续签2025-2027年销售框架协议</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑛泰医疗续签2025-2027年销售框架协议\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-23 10:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092310253495765695&s=b><strong>地产k线</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>瑛泰医疗（股票代码：01501）近日发布了补充公告，详细阐述了与康德莱的持续关联交易情况。公告指出，针对2025年至2027年的销售框架协议，双方将遵循公开招标程序来确定介入医疗器械的采购价格。定价机制将综合考虑地方政府的竞标规范、物流市场费用，以及瑛泰医疗自身的生产成本与市场合理利润率。此番设定的年度交易上限，是基于过往瑛泰医疗与康德莱的交易记录，并预见到中国医疗器械带量采购政策下市场需求增长的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092310253495765695&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603987","symbol_name":"康德莱","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092310253495765695&s=b","article_id":"2469744131","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092310253495765695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2469744131","pubTimestamp":1727057852,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"瑛泰医疗（股票代码：01501）近日发布了补充公告，详细阐述了与康德莱的持续关联交易情况。公告指出，针对2025年至2027年的销售框架协议，双方将遵循公开招标程序来确定介入医疗器械的采购价格。定价机制将综合考虑地方政府的竞标规范、物流市场费用，以及瑛泰医疗自身的生产成本与市场合理利润率。此番设定的年度交易上限，是基于过往瑛泰医疗与康德莱的交易记录，并预见到中国医疗器械带量采购政策下市场需求增长的趋势。此举旨在维护交易公平性，确保瑛泰医疗向康德莱提供的价格不低于其向独立第三方提供的水平，从而提升交易的透明度与市场竞争力。（综合财中社内容）","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603987":"康德莱","BK1222":"医疗保健用品","01501":"瑛泰医疗"},"translate_title":"Intec Medical renews 2025-2027 sales framework agreement","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603987":0.9,"01501":1},"content_text":"瑛泰医疗（股票代码：01501）近日发布了补充公告，详细阐述了与康德莱的持续关联交易情况。公告指出，针对2025年至2027年的销售框架协议，双方将遵循公开招标程序来确定介入医疗器械的采购价格。定价机制将综合考虑地方政府的竞标规范、物流市场费用，以及瑛泰医疗自身的生产成本与市场合理利润率。此番设定的年度交易上限，是基于过往瑛泰医疗与康德莱的交易记录，并预见到中国医疗器械带量采购政策下市场需求增长的趋势。此举旨在维护交易公平性，确保瑛泰医疗向康德莱提供的价格不低于其向独立第三方提供的水平，从而提升交易的透明度与市场竞争力。（综合财中社内容）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2469744131"}